Status:
NOT_YET_RECRUITING
This Study Evaluates the Impact of the Sodium Management Tool (SMT) on Hemodialysis Patient Outcomes Compared to Standard Care
Lead Sponsor:
Sharon-Rose Maloney
Conditions:
Hemodialysis
Interdialytic Weight Gain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Title of the Study: Sodium Management Tool in Hemodialysis Patients Brief Summary: The goal of this clinical trial is to learn whether the Sodium Management Tool (SMT) can improve patients clnical o...
Detailed Description
Title of the Study: Sodium Management Tool in Hemodialysis Patients Objectives This study aims to evaluate the impact of the Sodium Management Tool (SMT) by Fresenius on interdialytic weight gain and...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Outpatients on hemodialysis for at least three months,
- Dialysis three times a week, age \>/= 18,
- dialysis with a Fresenius 6008 Machine,
- signed informed consent
- Exclusion:
- Dialysis access with repeated Interruption due to flow problems
- plasma natrium \< 130 mmol/l, \> 145 mmol/l, pregnancy -
Exclusion
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06896786
Start Date
April 1 2025
End Date
August 31 2025
Last Update
March 26 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.